_version_ 1784806668197953536
author Reimann, Hannah
Kremer, Anita N.
Blumenberg, Viktoria
Schmidt, Katja
Aigner, Michael
Jacobs, Benedikt
Eisenhauer, Nina
Kämpf, Alina
Rösler, Wolf
Kharboutli, Soraya
Mougiakakos, Dimitrios
Lang, Vanessa
Lischer, Christopher
Irrgang, Pascal
Leppkes, Moritz
Gonzalez, Julio Vera
Krönke, Gerhard
Kremer, Andreas E.
Tenbusch, Matthias
Bruns, Heiko
Harrer, Thomas
Müller, Fabian
Schett, Georg
Mackensen, Andreas
Subklewe, Marion
Völkl, Simon
author_facet Reimann, Hannah
Kremer, Anita N.
Blumenberg, Viktoria
Schmidt, Katja
Aigner, Michael
Jacobs, Benedikt
Eisenhauer, Nina
Kämpf, Alina
Rösler, Wolf
Kharboutli, Soraya
Mougiakakos, Dimitrios
Lang, Vanessa
Lischer, Christopher
Irrgang, Pascal
Leppkes, Moritz
Gonzalez, Julio Vera
Krönke, Gerhard
Kremer, Andreas E.
Tenbusch, Matthias
Bruns, Heiko
Harrer, Thomas
Müller, Fabian
Schett, Georg
Mackensen, Andreas
Subklewe, Marion
Völkl, Simon
author_sort Reimann, Hannah
collection PubMed
description
format Online
Article
Text
id pubmed-9554322
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-95543222022-10-12 Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy Reimann, Hannah Kremer, Anita N. Blumenberg, Viktoria Schmidt, Katja Aigner, Michael Jacobs, Benedikt Eisenhauer, Nina Kämpf, Alina Rösler, Wolf Kharboutli, Soraya Mougiakakos, Dimitrios Lang, Vanessa Lischer, Christopher Irrgang, Pascal Leppkes, Moritz Gonzalez, Julio Vera Krönke, Gerhard Kremer, Andreas E. Tenbusch, Matthias Bruns, Heiko Harrer, Thomas Müller, Fabian Schett, Georg Mackensen, Andreas Subklewe, Marion Völkl, Simon Blood Adv Research Letter The American Society of Hematology 2022-10-12 /pmc/articles/PMC9554322/ /pubmed/36206194 http://dx.doi.org/10.1182/bloodadvances.2022007806 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Reimann, Hannah
Kremer, Anita N.
Blumenberg, Viktoria
Schmidt, Katja
Aigner, Michael
Jacobs, Benedikt
Eisenhauer, Nina
Kämpf, Alina
Rösler, Wolf
Kharboutli, Soraya
Mougiakakos, Dimitrios
Lang, Vanessa
Lischer, Christopher
Irrgang, Pascal
Leppkes, Moritz
Gonzalez, Julio Vera
Krönke, Gerhard
Kremer, Andreas E.
Tenbusch, Matthias
Bruns, Heiko
Harrer, Thomas
Müller, Fabian
Schett, Georg
Mackensen, Andreas
Subklewe, Marion
Völkl, Simon
Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy
title Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy
title_full Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy
title_fullStr Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy
title_full_unstemmed Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy
title_short Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy
title_sort cellular and humoral immune responses to sars-cov-2 vaccination in patients after cd19.car t-cell therapy
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554322/
https://www.ncbi.nlm.nih.gov/pubmed/36206194
http://dx.doi.org/10.1182/bloodadvances.2022007806
work_keys_str_mv AT reimannhannah cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT kremeranitan cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT blumenbergviktoria cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT schmidtkatja cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT aignermichael cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT jacobsbenedikt cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT eisenhauernina cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT kampfalina cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT roslerwolf cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT kharboutlisoraya cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT mougiakakosdimitrios cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT langvanessa cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT lischerchristopher cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT irrgangpascal cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT leppkesmoritz cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT gonzalezjuliovera cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT kronkegerhard cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT kremerandrease cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT tenbuschmatthias cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT brunsheiko cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT harrerthomas cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT mullerfabian cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT schettgeorg cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT mackensenandreas cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT subklewemarion cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy
AT volklsimon cellularandhumoralimmuneresponsestosarscov2vaccinationinpatientsaftercd19cartcelltherapy